Physical and Emotional Coping Variables in Climacteric Women

NCT ID: NCT05505266

Last Updated: 2022-11-14

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-09-01

Study Completion Date

2022-11-11

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Introduction: The transition to menopause entails several changes in the biopsychosocial sphere of climacteric women. Compared to other therapies, physical exercise has no side effects, is not costly and can have a positive influence on the symptoms reported by women at this stage. The emotional and physical state of climacteric women is affected by the alterations typical of menopause, deteriorating their quality of life. Likewise, physical exercise improves the associated symptomatology. The objective is to know how the study variables (symptomatology, quality of life, emotional state, physical exercise and level of coping) correlate.

Material and methods: Cross-sectional descriptive observational design with a study population made up of women in the climacteric stage carried out through an anonymous and voluntary survey.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The climacteric is a progressive period, which lasts for years, before and after menopause, the latter being the physiological stage of aging characterized by the decrease in the follicular function of the ovaries that ends with the cessation of menstrual periods. permanent, a phenomenon associated with the decrease in the production of hormones, as well as the arrest by the ovaries in the release of ovules. Menopause most commonly occurs between the ages of 45 and 55. The climacteric is experienced by each woman in a different way, since it is also influenced by biopsychosocial factors, but the investigators can speak of a common symptomatology typical of the climacteric that groups together vasomotor symptoms such as hot flashes and palpitations, psychological symptoms such as changes in mood, depression, irritability and anxiety, alterations in sleep quality, cognitive symptoms such as memory loss, among others. Among the therapies to alleviate the symptoms associated with menopause, the investigators find estrogenic and non-estrogenic hormonal therapies, inhibitors and physical exercise.

Despite the lack of evidence to support physical exercise as a tool to eradicate symptoms linked to menopause, the investigators can affirm that it relieves both somatic and psychological symptoms, and vasomotor and sexual symptoms to a lesser extent, which is associated with an improvement overall quality of life. In addition, with regular physical activity the investigators will be able to strengthen the musculoskeletal system and improve the quality of life.

The investigators found a scarcity of studies that relate therapeutic exercise as a physiotherapeutic tool in relieving the symptomatology of climacteric women, for this reason the need to study the activity they carry out in this area and know its characteristics is raised, in order to guide future strategies in physiotherapy.

Objective: To know the physical exercise carried out by women in this period, to know the existence of levels of anxiety and depression, Coping level and quality of life.

Material and methods Subjects: Women between 40 and 60 years old. For the development of the study, a questionnaire is prepared, which consists of an initial section with basic questions about personal data and symptomatology referred to by each subject, to later move on to the rest of the sections that will include questions from other validated questionnaires: quality of life using the SF -12; For the emotional state, the Goldberg scale; For physical activity, the International Physical Activity Questionnaire (IPAQ); And for coping level, the Brief COPE inventory.

At the end, 2 questions are included about how often they go to a physical therapist to deal with musculoskeletal pain.

Once the questionnaire is closed, the results will be analyzed using SPSS, which will allow us to contrast hypotheses and generate new ones.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Menopausal Women

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

observational

observational

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Climacteric women
* Age between 40 and 60 years.

Exclusion Criteria

\- Not having internet access to complete the questionnaire.
Minimum Eligible Age

40 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Valencia

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

GEMMA V ESPÍ LÓPEZ, PhD

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gemma V Espí-López

Valencia, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ID0037

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.